R&R, Inc.
🇺🇸United States
Clinical Trials
1
Active:0
Completed:1
Trial Phases
1 Phases
Phase 2:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 2
1 (100.0%)Phase II Study of RR110 in Patients With Active Crohn's Disease
Phase 2
Completed
- Conditions
- Crohn's Disease
- Interventions
- Drug: RR110 (Tamibarotene)
- First Posted Date
- 2007-01-01
- Last Posted Date
- 2008-05-29
- Lead Sponsor
- R&R Inc.
- Target Recruit Count
- 24
- Registration Number
- NCT00417391
News
No news found